These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33022824)

  • 1. Essential tobacco dependence medicines in 137 countries.
    Benipal S; Budhram DR; Bilimoria K; Woods H; Wang R; Persaud N
    Addiction; 2021 Jun; 116(6):1606-1609. PubMed ID: 33022824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterising the use of varenicline: an analysis of the Australian dispensing claims data.
    Gobarani RK; Ilomäki J; Wood S; Abramson MJ; Bonevski B; George J
    Addiction; 2022 Oct; 117(10):2683-2694. PubMed ID: 35603915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine dependence and smoking cessation.
    Tan L; Tang Q; Hao W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1049-57. PubMed ID: 19952392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tobacco cessation treatment for people with schizophrenia].
    Papachristou C; Humair JP
    Rev Med Suisse; 2022 Jun; 18(787):1275-1278. PubMed ID: 35735153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of tobacco dependence: integrating recent progress into practice.
    Le Foll B; George TP
    CMAJ; 2007 Nov; 177(11):1373-80. PubMed ID: 18025429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Centers for tobacco-dependent in the Czech Republic in 2016].
    Zvolská K; Králíková E
    Cas Lek Cesk; 2017; 156(1):19-23. PubMed ID: 28264577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological intervention of nicotine dependence.
    Jain R; Majumder P; Gupta T
    Biomed Res Int; 2013; 2013():278392. PubMed ID: 24490153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.
    Giulietti F; Filipponi A; Rosettani G; Giordano P; Iacoacci C; Spannella F; Sarzani R
    High Blood Press Cardiovasc Prev; 2020 Oct; 27(5):349-362. PubMed ID: 32578165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
    Kozak K; George TP
    Expert Opin Pharmacother; 2020 Apr; 21(5):581-590. PubMed ID: 32011186
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review.
    Antoniu SA; Buculei I; Mihaltan F; Crisan Dabija R; Trofor AC
    Expert Opin Pharmacother; 2021 May; 22(7):835-847. PubMed ID: 33372557
    [No Abstract]   [Full Text] [Related]  

  • 16. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Smoking cessation: Pharmacological strategies different from standard treatments].
    Underner M; Perriot J; Peiffer G; Harika-Germaneau G; Jaafari N
    Rev Pneumol Clin; 2018 Sep; 74(4):205-214. PubMed ID: 29773262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation and the effect of nicotine dependence on relapse rate in Izmir, Turkey.
    Pekel Ö; Ergör G; Günay T; Baydur H; Choussein B; Budak R; Doğanay S
    Turk J Med Sci; 2015; 45(4):895-901. PubMed ID: 26422864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to increase adherence to medications for tobacco dependence.
    Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.